Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
12/2005
12/14/2005EP1604975A1 Processes for production of (r)-3- 4-(trifluoromethyl)- phen ylamino pentanamide derivatives
12/14/2005EP1604212A2 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1154989B1 Vanilloid analogues containing resiniferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1706815A Improved prepn process of itopride medicine material
12/13/2005US6974567 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
12/13/2005CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds
12/08/2005WO2005082860A8 Tetracyclines and their use as calpain inhibitors
12/08/2005US20050272815 Compounds and compositions for delivering active agents
12/08/2005US20050272731 stereospecific saponification of a racemic ester using a lipase enzyme, then reduction of a beta -keto amide and esters, to form chemical intermediate for 16-membered macrolide rings used as antitumor agents
12/08/2005US20050272639 Crystalline polymorph of the pentahydrate form in synergistic combination with another active ingredient to enhance drug delivery; antidiabetic agents
12/08/2005US20050272638 Improved bioavailability; for oral and intracolonic administration
12/08/2005US20050272036 Ketones
12/08/2005DE102004023508A1 Säurederivate substituierter Cyclohexyl-1,4-diamine Acid derivatives substituted cyclohexyl-1,4-diamine
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1601384A1 Methods of radiofluorination of biologically active vectors
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/07/2005CN1230418C Selective androgen receptor modulators and methods of use thereof
12/06/2005US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
12/06/2005US6972300 Compounds and compositions for delivering active agents
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005CA2235840C Phenylethanolamine compounds useful as .beta.3 agonist, process for producing the same, and intermediates in the production of the same
12/06/2005CA2206787C 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
12/01/2005WO2005113565A2 Metabolites of selective androgen receptor modulators and methods of use thereof
12/01/2005WO2005113495A1 Method for producing diphenyl azetidinone derivatives
12/01/2005WO2005113489A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
12/01/2005WO2005113485A2 Stable nateglinide form b compositions
12/01/2005WO2005113484A1 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
12/01/2005WO2005112943A1 Topical cromolyn formulations
12/01/2005WO2005060603A3 Nitric oxide releasing pyruvate compounds, compositions and methods of use
12/01/2005US20050267199 2-Amino- and 2-thio- substituted 1,3-diaminopropanes
12/01/2005US20050267170 Substituted methyl aryl or heteroaryl amide compounds
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005US20050267079 Tetracycline derivatives and methods of use thereof
12/01/2005DE102004023506A1 Kettenverlängerte substituierte Cyclohexyl-1,4-diamin-Derivate Chain-substituted cyclohexyl-1,4-diamine derivatives
12/01/2005DE102004023501A1 Oxosubstituierte Cyclohexyl-1,4-diamin-Derivate Oxosubstituierte cyclohexyl-1,4-diamine derivatives
12/01/2005CA2567481A1 Method for producing diphenyl azetidinone derivatives
12/01/2005CA2566747A1 Topical cromolyn formulations
12/01/2005CA2566090A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
12/01/2005CA2566053A1 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
12/01/2005CA2563908A1 Metabolites of selective androgen receptor modulators and methods of use thereof
11/2005
11/30/2005EP1599496A2 Hepatitis c inhibitor peptide analogs
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229335C Nervinolin derivatives
11/24/2005WO2005110975A1 Substituted cyclohexyl-1,4-diamine derivatives with a chain extension
11/24/2005WO2005110973A1 Acid derivatives of substituted cyclohexyl-1,4-diamines
11/24/2005WO2005110970A1 Oxo-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005110395A1 System and device for magnetic drug targeting with magnetic drug carrier particles
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005CA2566210A1 Oxo-substituted cyclohexyl-1,4-diamine derivatives
11/23/2005EP1598334A1 Thyroid hormone analogues and methods for their preparation
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005EP1320522B1 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
11/23/2005CN1700923A Multi-substituted selective androgen receptor modulators and methods of use thereof
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/22/2005CA2187174C .alpha.-substituted phenylacetic acid derivative, process for producing the same, and agricultural bactericide containing the same
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108338A1 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005107462A2 Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
11/17/2005US20050256336 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
11/17/2005US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
11/17/2005US20050256201 Phenethanolamine derivatives
11/17/2005US20050256198 2-[(4-{3-[benzyl(hexyl)amino]-3-oxopropyl}phenoxy)methyl]benzoic acid;peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations
11/17/2005US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050255138 Active agent transport systems
11/17/2005DE102004019472A1 Phenylacetamide Phenylacetamides
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2563681A1 Crystalline polymorphic forms of monosodium n-[8-(2-hydroxybenzoyl)amino]caprylate
11/16/2005EP1594846A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
11/16/2005EP1487796A4 Substituted biaryl amides as c5a receptor modulators
11/15/2005CA2268031C Lubricity additives for fuel oil compositions
11/15/2005CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/10/2005WO2005105744A1 Histamine-3 receptor antagonists
11/10/2005WO2005105733A1 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005WO2005105732A1 Substituted methyl aryl or heteroaryl amide compounds
11/10/2005WO2005105731A1 Novel crystalline calcium pantothenate
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005US20050250852 For facilitating the delivery of active agents, such as insulin, to a target
11/10/2005US20050250819 Inhibitors of bacterial type III protein secretion systems
11/10/2005US20050250818 Ortho substituted aryl or heteroaryl amide compounds
11/10/2005US20050250116 Universal supports for oligonucleotide synthesis
11/10/2005US20050249665 Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
11/10/2005CA2564258A1 Histamine-3 receptor antagonists
11/09/2005EP1593378A1 Remedy for viral disease
11/09/2005EP1592658A2 Large-scale synthesis of selective androgen receptor modulators
11/09/2005EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties
11/09/2005EP1149066B1 Method of preparing alkylated salicylamides
11/09/2005EP0981554A4 Chloride linker for solid phase organic synthesis
11/09/2005CN1694865A Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
11/09/2005CN1226277C Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
11/08/2005US6962693 Alkylpolypropyleneoxide amidotriamines and method of using same
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/03/2005WO2005103001A1 Phenyl acetamides
11/03/2005WO2005102989A1 Non-nucleoside reverse transcriptase inhibitors
11/03/2005WO2005102388A1 Novel blt2-mediated disease, and blt2 binding agent and compound
1 ... 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 ... 157